Status:
UNKNOWN
Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.
Lead Sponsor:
Kafrelsheikh University
Conditions:
Renal Stones
Nephrolithiasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Efficacy of tranexamic acid on blood loss during percutaneous nephrolithotomy. a double-blind, placebo-controlled randomized clinical trial.
Detailed Description
To evaluate whether intravenous tranexamic acid or tranexamic acid in the irrigation fluid in percutaneous nephrolithotomy (PCNL) in reducing bleeding during and after PCNL.
Eligibility Criteria
Inclusion
- Patient 18 years or older
- Stones ≥ 2 cm and/or mild to moderate hydronephrosis.
Exclusion
- Age \<18 years or Pregnancy
- Bilateral simultaneous PCNL
- Morbid obesity (BMI \>40)
- Refuse to complete study requirements
- Untreated UTI
- Atypical bowel interposition by CT
- Tumour in the presumptive access tract area or Potential malignant kidney tumour
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04367155
Start Date
September 1 2019
End Date
March 1 2022
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt